[SCHEDULE 13G/A] Context Therapeutics Inc. SEC Filing

Rhea-AI Filing Summary

Avidity Partners and affiliated funds filed a Schedule 13G reporting significant passive holdings in Context Therapeutics Inc. The filing discloses that certain Avidity reporting persons hold shared voting and shared dispositive power over 9,126,176 shares, representing approximately 9.9% of the outstanding common stock. Individual fund positions reported in the filing include Avidity Master Fund LP with 5,183,700 shares (5.6%) and Avidity Private Master Fund I LP with 7,776,296 shares (8.4%). Michael Gregory is listed among the reporting persons with the same shared power totaling 9,126,176 shares.

The filing indicates no sole voting or dispositive power for any reporting person and includes a certification that the securities were not acquired to change or influence control of the issuer. Exhibits referenced in the filing include a Joint Filing Agreement and Control Person Identification.

Positive

• Reported beneficial ownership of 9,126,176 shares representing 9.9% of Context Therapeutics common stock.
• Detailed fund-level positions disclosed, including 5,183,700 shares (5.6%) for Avidity Master Fund LP and 7,776,296 shares (8.4%) for Avidity Private Master Fund I LP.
• Filed Schedule 13G with a certification of passive intent and included exhibits (Joint Filing Agreement and Control Person Identification) as part of the disclosure.

Negative

• None.

Insights

Financial Analyst

TL;DR: Avidity reports a material passive stake of 9.9% in CNTX with shared voting/dispositive power; this is a notable ownership disclosure for investors.

The Schedule 13G shows Avidity-affiliated entities collectively holding 9,126,176 shares (9.9%) of Context Therapeutics common stock and reporting only shared voting and dispositive powers. The filing is a passive disclosure rather than an active 13D claim, and it includes a formal certification that the holdings were not acquired to influence control. For investors, the key facts are the size of the position and the coordinated reporting across multiple Avidity entities, both explicitly stated in the filing.

Corporate Governance Expert

TL;DR: Coordinated Avidity ownership is disclosed as passive (Schedule 13G) with shared powers; governance impact is limited absent additional actions.

The filing documents shared voting and dispositive power across several Avidity entities rather than any sole control. Reported fund-level holdings include 5,183,700 shares (5.6%) for Avidity Master Fund LP and 7,776,296 shares (8.4%) for Avidity Private Master Fund I LP, with aggregate shared power of 9,126,176 shares (9.9%). The report includes a certification stating the securities were not acquired to change or influence control and attaches a Joint Filing Agreement and Control Person Identification exhibit, all as stated in the document.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

Context Therapeutics Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

21077P108

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 21077P108

1

Names of Reporting Persons

Avidity Partners Management LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 9,126,176.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 9,126,176.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

9,126,176.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

IA, PN

SCHEDULE 13G

CUSIP No. 21077P108

1

Names of Reporting Persons

Avidity Partners Management (GP) LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 9,126,176.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 9,126,176.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

9,126,176.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 21077P108

1

Names of Reporting Persons

Avidity Capital Partners Fund (GP) LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 9,126,176.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 9,126,176.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

9,126,176.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 21077P108

1

Names of Reporting Persons

Avidity Capital Partners (GP) LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 9,126,176.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 9,126,176.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

9,126,176.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 21077P108

1

Names of Reporting Persons

Avidity Master Fund LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 5,183,700.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 5,183,700.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

5,183,700.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.6 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 21077P108

1

Names of Reporting Persons

Avidity Private Master Fund I LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,776,296.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,776,296.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,776,296.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.4 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 21077P108

1

Names of Reporting Persons

Michael Gregory

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 9,126,176.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 9,126,176.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

9,126,176.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Context Therapeutics Inc.
(b)	Address of issuer's principal executive offices: 2001 Market Street, Suite 3915, Unit #15, Philadelphia, Pennsylvania 19103
Item 2.
(a)	Name of person filing: Avidity Partners Management LP Avidity Partners Management (GP) LLC Avidity Capital Partners Fund (GP) LP Avidity Capital Partners (GP) LLC Avidity Master Fund LP Avidity Private Master Fund I LP Michael Gregory
(b)	Address or principal business office or, if none, residence: Avidity Partners Management LP 2828 N Harwood Street, Suite 1220 Dallas, Texas 75201 United States of America Avidity Partners Management (GP) LLC 2828 N Harwood Street, Suite 1220 Dallas, Texas 75201 United States of America Avidity Capital Partners Fund (GP) LP 2828 N Harwood Street, Suite 1220 Dallas, Texas 75201 United States of America Avidity Capital Partners (GP) LLC 2828 N Harwood Street, Suite 1220 Dallas, Texas 75201 United States of America Avidity Master Fund LP 2828 N Harwood Street, Suite 1220 Dallas, Texas 75201 United States of America Avidity Private Master Fund I LP 2828 N Harwood Street, Suite 1220 Dallas, Texas 75201 United States of America Michael Gregory c/o Avidity Partners Management LP 2828 N Harwood Street, Suite 1220 Dallas, Texas 75201 United States of America
(c)	Citizenship: Avidity Partners Management LP - Delaware Avidity Partners Management (GP) LLC - Delaware Avidity Capital Partners Fund (GP) LP - Delaware Avidity Capital Partners (GP) LLC - Delaware Avidity Master Fund LP - Cayman Islands Avidity Private Master Fund I LP - Cayman Islands Michael Gregory - United States
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP No.: 21077P108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Avidity Partners Management LP - 9,126,176 Avidity Partners Management (GP) LLC - 9,126,176 Avidity Capital Partners Fund (GP) LP - 9,126,176 Avidity Capital Partners (GP) LLC - 9,126,176 Avidity Master Fund LP - 5,183,700 Avidity Private Master Fund I LP - 7,776,296 Michael Gregory - 9,126,176
(b)	Percent of class: Avidity Partners Management LP - 9.9% Avidity Partners Management (GP) LLC - 9.9% Avidity Capital Partners Fund (GP) LP - 9.9% Avidity Capital Partners (GP) LLC - 9.9% Avidity Master Fund LP - 5.6% Avidity Private Master Fund I LP - 8.4% Michael Gregory - 9.9%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Avidity Partners Management LP - 0 Avidity Partners Management (GP) LLC - 0 Avidity Capital Partners Fund (GP) LP - 0 Avidity Capital Partners (GP) LLC - 0 Avidity Master Fund LP - 0 Avidity Private Master Fund I LP - 0 Michael Gregory - 0
	(ii) Shared power to vote or to direct the vote: Avidity Partners Management LP - 9,126,176 Avidity Partners Management (GP) LLC - 9,126,176 Avidity Capital Partners Fund (GP) LP - 9,126,176 Avidity Capital Partners (GP) LLC - 9,126,176 Avidity Master Fund LP - 5,183,700 Avidity Private Master Fund I LP - 7,776,296 Michael Gregory - 9,126,176
	(iii) Sole power to dispose or to direct the disposition of: Avidity Partners Management LP - 0 Avidity Partners Management (GP) LLC - 0 Avidity Capital Partners Fund (GP) LP - 0 Avidity Capital Partners (GP) LLC - 0 Avidity Master Fund LP - 0 Avidity Private Master Fund I LP - 0 Michael Gregory - 0
	(iv) Shared power to dispose or to direct the disposition of: Avidity Partners Management LP - 9,126,176 Avidity Partners Management (GP) LLC - 9,126,176 Avidity Capital Partners Fund (GP) LP - 9,126,176 Avidity Capital Partners (GP) LLC - 9,126,176 Avidity Master Fund LP - 5,183,700 Avidity Private Master Fund I LP - 7,776,296 Michael Gregory - 9,126,176
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Please see Exhibit B attached hereto.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Avidity Partners Management LP

Signature:	By: Avidity Partners Management (GP) LLC, its general partner, By: /s/ Michael Gregory
Name/Title:	Michael Gregory/Managing Member
Date:	08/14/2025

Avidity Partners Management (GP) LLC

Signature:	/s/ Michael Gregory
Name/Title:	Michael Gregory/Managing Member
Date:	08/14/2025

Avidity Capital Partners Fund (GP) LP

Signature:	By: Avidity Capital Partners (GP) LLC, its general partner, By: /s/ Michael Gregory
Name/Title:	Michael Gregory/Managing Member
Date:	08/14/2025

Avidity Capital Partners (GP) LLC

Signature:	/s/ Michael Gregory
Name/Title:	Michael Gregory/Managing Member
Date:	08/14/2025

Avidity Master Fund LP

Signature:	By: Avidity Capital Partners Fund (GP) LP, its general partner, By: Avidity Capital Partners (GP) LLC, its general partner, By: /s/ Michael Gregory
Name/Title:	Michael Gregory/Managing Member
Date:	08/14/2025

Avidity Private Master Fund I LP

Signature:	By: Avidity Capital Partners Fund (GP) LP, its general partner, By: Avidity Capital Partners (GP) LLC, its general partner, By: /s/ Michael Gregory
Name/Title:	Michael Gregory/Managing Member
Date:	08/14/2025

Michael Gregory

Signature:	/s/ Michael Gregory
Name/Title:	Michael Gregory
Date:	08/14/2025

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Exhibit Information

[Exhibit A - Joint Filing Agreement] [Exhibit B - Control Person Identification]

FAQ

How many shares of CNTX does Avidity beneficially own?

The filing reports aggregated shared beneficial ownership of 9,126,176 shares of Context Therapeutics (CNTX).

What percentage of CNTX common stock does Avidity report owning?

Avidity and affiliated reporting persons disclose ownership equal to approximately 9.9% of CNTX common stock.

Do any reporting persons have sole voting or dispositive power over the shares?

No; the filing states 0 sole voting power and 0 sole dispositive power for each reporting person, with only shared powers reported.

Which Avidity funds are specifically identified and what are their reported holdings?

The filing lists Avidity Master Fund LP with 5,183,700 shares (5.6%) and Avidity Private Master Fund I LP with 7,776,296 shares (8.4%), among other Avidity entities reporting shared power.

Does the filing state intent to influence control of Context Therapeutics (CNTX)?

The filing includes a certification stating the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.